Inflammation, DAMPs, tumor development, and progression: A vicious circle orchestrated by redox signaling

Antioxidants and Redox Signaling

Volumn 20, Issue 7, 2014, Pages 1086-1097

  Castellani, Patrizia ^a   Balza, Enrica ^a   Rubartelli, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIOXIDANTS; CARCINOGENESIS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84894031033     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5164     Document Type: Review

References (103)

1. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G, Clarke F, Sitia R, and Rubartelli A. Antigenpresenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A 99: 1491-1496, 2002.
2. Balza E, Castellani P, Delfino L, Truini M, and Rubartelli A. The pharmacologic inhibition of the xc-Antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis. Carcinogenesis 34: 620-626, 2012.
3. Banjac A, Perisic T, Sato H, Seiler A, Bannai S, Weiss N, Kö lle P, Tschoep K, Issels RD, Daniel PT, Conrad M, and Bornkamm GW. The cystine/cysteine cycle: A redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27: 1618-1628, 2008.
4. Baron JA and Sandlers RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu RevMed 51: 511-523, 2000.
5. Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, and Lukyanov S. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat Methods 3: 281-286, 2006.
6. Blakytny R, Erkell LJ, and Brunner G. Inactivation of active and latent transforming growth factor beta by free thiols: Potential redox regulation of biological action. Int J Biochem Cell Biol 38: 1363-1373, 2006.
7. Brown JR and DuBois RN. COX-2: A molecular target for colorectal cancer prevention. J Clin Oncol 23: 2840-2855, 2005.
8. Camby I, Le Mercier M, Lefranc F, and Kiss R. Galectin-1: A small protein with major functions. Glycobiology 16: 137R-157R, 2006.
9. Carta S, Tassi S, Pettinati I, Delfino L, Dinarello CA, and Rubartelli A. The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Tolllike receptor triggering. J Biol Chem 286: 27069-27080, 2011.
10. Ceccarelli J, Delfino L, Zappia E, Castellani P, Borghi M, Ferrini S, Tosetti F, and Rubartelli A. The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants. Int J Cancer 123: 1770-1778, 2008.
11. Cerutti PA. Prooxidant states and tumor promotion. Science 227: 375-381, 1985.
12. Chang TS, Jeong W, Woo HA, Lee SM, Park S, and Rhee SG. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem 279: 50994-51001, 2004.
13. Chang YJ, Myung SK, Chung ST, Kim Y, Lee EH, Jeon YJ, Park CH, Seo HG, and Huh BY. Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: A meta-Analysis of randomized controlled trials. Dermatology 223: 36-44, 2011.
14. Chen XP, Zhong ZF, Xu ZT, and Chen LD, Wang YT. 2¢,7¢- Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radic Res 44: 587-604, 2010.
15. Chigaev A, Zwartz GJ, Buranda T, Edwards BS, Prossnitz ER, and Sklar LA. Conformational regulation of a 4 b 1-integrin affinity by reducing agents: 'inside-out' signaling is independent of and additive to reduction regulated integrin activation. J Biol Chem 279: 32435-32443, 2004.
16. Chung WJ and Sontheimer H. Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB. J Neurochem 110: 182-193, 2009.
17. Cole SP and Deeley RG. Transport of glutathione and glutathione conjugates by mrp1. Trends Pharmacol Sci 27: 438-446, 2006.
18. Conrad M and Sato H. The oxidative stress-inducible cystine/ glutamate antiporter, system x (c) (-): Cystine supplier and beyond. Amino Acids 42: 231-246, 2012.
19. Cooke MS, et al. Oxidative DNA damage: Mechanisms, mutation, and disease FASEB J 17: 1195-1214, 2003.
20. Curbo S, Gaudin R, Carlsten M, Malmberg KJ, Troye-Blomberg M, Ahlborg N, Karlsson A, Johansson M, and Lundberg M. Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides. Biochem Biophys Res Commun 390: 1272-1277, 2009.
21. D'Autréaux B and Toledano MB. ROS as signaling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824, 2007.
22. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, and Tuveson DA. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475: 106-109, 2011.
23. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, and Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458: 780-783, 2009.
24. Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, and Tsien RY. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem 279: 22284-22293, 2004.
25. Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, and Wang YZ. Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy. Prostate 67: 162-171, 2007.
26. Durackova Z. Some current insights into oxidative stress. Physiol Res 59: 459-469, 2010.
27. Echigo Y, Sugiki H, Koizumi Y, Hikitsuchi S, and Inoue H. Activation of RAW264.7 macrophages by oxidized galectin-1. Immunol Lett 13: 19-23, 2010.
28. Ehrchen JM, Sunderkö tter C, Foell D, Vogl T, and Roth J. The endogenous Toll-like receptor 4 agonist S100A8/ S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86: 557-566, 2009.
29. Ellgaard A. Helenius Quality control in the endoplasmic reticulum Nat Rev Mol Cell Biol 4: 181-191, 2003.
30. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248-253, 1998.
31. Fritz H, Kennedy D, Fergusson D, Fernandes R, Cooley K, Seely A, Sagar S, Wong R, and Seely D. Selenium and lung cancer: A systematic review and meta analysis. PLoS One 6: E26259, 2011.
32. García-Rodríguez LA and Huerta-Alvarez C. Reduced risk of colorectal cancer among long-Term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12: 88-93, 2001.
33. Gius D and Spitz DR. Redox signaling in cancer biology. Antioxid Redox Signal 8: 1249-1252, 2006.
34. Goplen D, Wang J, Enger PO, Tysnes BB, Terzis AJ, Laerum OD, and Bjerkvig R. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 66: 9895-9902, 2006.
35. Haase-Kohn C, Wolf S, Lenk J, and Pietzsch J. Coppermediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells. Biochem Biophys Res Commun 413: 494-498, 2011.
36. Hayes JD and Mcmahon M. The double-edged sword of Nrf2: Subversion of redox homeostasis during the evolution of cancer. Mol Cell 21: 732-734, 2006.
37. Hervé C, Tonon T, Collén J, Corre E, and Boyen C. NADPH oxidases in eukaryotes: Red algae provide new hints. Curr Genet 49: 190-204, 2006.
38. Horie H, Kadoya T, Sango K, and Hasegawa M. Oxidized galectin-1 is an essential factor for peripheral nerve regeneration Curr Drug Targets 6: 385-394, 2005.
39. Hwang C, Lodish HF, and Sinskey AJ. Measurement of glutathione redox state in cytosol and secretory pathway of cultured cells. Methods Enzymol 251: 212-221, 1995.
40. Inagaki Y, Sohma Y, Horie H, Nozawa R, and Kadoya T. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur J Biochem 267: 2955-2964, 2000.
41. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431: 997-1002, 2004.
42. Jeon YJ, Myung SK, Lee EH, Kim Y, Chang YJ, Ju W, Cho HJ, Seo HG, and Huh BY. Effects of beta-carotene supplements on cancer prevention: Meta-Analysis of randomized controlled trials. Nutr Cancer 63: 1196-1207, 2011.
43. Jiang K, Schwarzer C, Lally E, Zhang S, Ruzin S, Machen T, Remington SJ, and Feldman L. Expression and characterization of a redox-sensing green fluorescent protein (reduction-oxidation-sensitive green fluorescent protein) in Arabidopsis. Plant physiol 141: 397-403, 2006.
44. Jiang L, Yang KH, Tian JH, Guan QL, Yao N, Cao N, Mi DH, Wu J, Ma B, and Yang SH. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer pre-vention: A meta-Analysis of randomized controlled trials. Nutr Cancer 62: 719-727, 2010.
45. Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W, and Zhang DD. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 70: 5486-5496, 2010.
46. Jordan PA and Gibbins JM. Extracellular disulfide exchange and the regulation of cellular function. Antioxid Redox Signal 8: 312-324, 2006.
47. Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, and Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 72: 3290-3301, 2012.
48. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, and Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspasedependent oxidation of highmobility group box-1 protein. Immunity 29: 21-32, 2008.
49. Klatt P and Lamas S. Regulation of protein function by Sglutathionylation in response to oxidative and nitrosative stress. Eur J Biochem 267: 4928-4944, 2000.
50. Kobayashi M and Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7: 385-394, 2005.
51. Lackman RL, Jamieson AM, Griffith JM, Geuze H, and Cresswell P. Innate immune recognition triggers secretion of lysosomal enzymes by macrophages. Traffic 8: 1179-1189, 2007.
52. Lecane PS, Karaman MW, Sirisawad M, Naumovski L, Miller RA, Hacia JG, and Magda D. Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res 65: 11676-11688, 2005.
53. Lesiak K, Koprowska K, Zalesna I, Nejc D, Duchler M, and Czyz M. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro. Melanoma Res 20: 21-34, 2010.
54. Leto TL, Morand S, Hurt D, and Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11: 2607-2619, 2009.
55. Lim SY, Raftery MJ, and Geczy CL. Oxidative modifications of DAMPs suppress inflammation: The case for S100A8 and S100A9. Antioxid Redox Signal 15: 2235-2248, 2011.
56. Lo M, Ling V, Low C,Wang YZ, and Gout PW. Potential use of the antiinflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Curr Oncol 17: 9-16, 2010.
57. Lo M, Ling V, Wang YZ, and Gout PW. The xc-cystine/ glutamate antiporter: A mediator of pancreatic cancer growth with a role in drug resistance. Br J Cancer 99: 464-472, 2008.
58. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tö r M, and Billiar T. The grateful dead: Damage-Associated molecular pattern molecules and reduction/oxidation regulate immunity Immunol Rev 220: 60-81, 2007.
59. Lu W, Ogasawara MA, and Huang P. Models of reactive oxygen species in cancer. Drug Discov Today Dis Models 4: 67-73, 2007.
60. Mantovani A, Allavena P, Sica A, and Balkwill F. Cancerrelated inflammation. Nature 454: 436-444, 2008.
61. Merksamer PI, Trusina A, and Papa FR. Real-Time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell 135: 933-947, 2008.
62. Metcalfe C, Cresswell P, Ciaccia L, Thomas B, and Barclay AN. Labile disulfide bonds are common at the leucocyte cell surface. Open Biol 1: 110010, 2011.
63. Meyer AJ and Dick TP. Fluorescent protein-based redox probes. Antioxid Redox Signal 13: 621-650, 2010.
64. Mieyal JJ and Chock PB. Posttraslational modification of cysteine in redox signaling and oxidative stress: Focus on Sglutathionilation. Antioxid Redox Signal 16: 471-475, 2012.
65. Myung SK, Kim Y, Ju W, Choi HJ, and Bae WK. Effects of antioxidant supplements on cancer prevention: Meta-Analysis of randomized controlled trials. Ann Oncol 21: 166-179, 2010.
66. Nakahira K, Haspel JA, Rathinam VAK, Lee S-J, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, and Choi AM. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230, 2011.
67. Naviaux RK. Oxidative shielding or oxidative stress?. J Pharmacol Exp Ther 342: 608-618, 2012.
68. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, and Hirohashi S. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68: 1303-1309, 2008.
69. Papaiahgari S, Kleeberger SR, Cho HY, Kalvakolanu DV, and Reddy SP. NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells. J Biol Chem 279: 42302-42312, 2004.
70. Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, Tappenden P, and Logan RF. Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: A systematic review and metaanalysis. Colorectal Dis 13: 1085-1099, 2011.
71. Pastore A, Federici G, Bertini E, and Piemonte F. Analysis of glutathione:implication in redox and detoxification. Clin Chim Acta 1: 19-39, 2003.
72. Powis G and Kirkpatrick DL. Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol 7: 392-397, 2007.
73. Ray PD, Huang BW, and Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981-990, 2012.
74. Rubartelli A, Bajetto A, Allavena G, Wollman E, and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267: 24161-24164, 1992.
75. Rubartelli A, Gattorno M, Netea MG, and Dinarello CA. Interplay between redox status and inflammasome activation. Trends Immunol 32: 559-566, 2011.
76. Rubartelli A and Lotze MT. Inside, outside, upside down: Damage-Associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 28: 429-436, 2007.
77. Rubartelli A and Sitia R. Stress as an intercellular signal: The emergence of stressassociated molecular patterns (SAMP). Antioxid Redox Signal 11: 2621-2629, 2009.
78. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, Beisner J, Buchner J, Schaller M, Stange EF, and Wehkamp J. Reduction of disulphide bonds unmasks potent antimicrobial activity of human b-defensin 1. Nature 469: 419-423, 2011.
79. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, and Hirohashi S. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A 105: 13568-13573, 2008.
80. Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, Gabrielson E, Feinstein E, and Biswal S. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res 68: 7975-7984, 2008.
81. Skalska J, Brookes PS, Nadtochiy SM, Hilchey SP, Jordan CT, Guzman ML, Maggirwar SB, Briehl MM, and Bernstein SH. Modulation of cell surface protein free thiols: A potential novel mechanism of action of the sesquiterpene lactone parthenolide. PLoS One 4: E8115, 2009.
82. Smith J, Ladi E, Mayer-Proschel M, and Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci U S A 97: 10032-10037, 2000.
83. Söderberg A, Hossain A, and Rosén A. A protein-disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane TNF-receptors: Overexpression in chronic lymphocytic leukemia cells. Antioxid Redox Signal 18: 363-375, 2013.
84. Söderberg A, Sahaf B, and Rosén A. Thioredoxin reductase, a redox-Active selenoprotein, is secreted by normal and neoplastic cells: Presence in human plasma. Cancer Res 60: 2281-2289, 2000.
85. Soini Y, Kahlos K, Napankangas U, Kaarteenaho-Wiik R, Saily M, Koistinen P, Paaakko P, Holmgren A, and Kinnula VL. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res 7: 1750-1757, 2001.
86. Tassi S, Carta S, Venè R, Delfino L, Ciriolo MR, and Rubartelli A. Pathogeninduced interleukin-1beta processing and secretion is regulated by a biphasic redox response. J Immunol 183: 1456-1462, 2009.
87. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, and Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10: 241-252, 2006.
88. Tsatmali M, Walcott EC, and Crossin KL. Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors. Brain Res 1040: 137-150, 2005.
89. Turano C, Coppari S, Altieri F, and Ferraro A. Proteins of the PDI family: Unpredicted non-ER locations and functions. J Cell Physiol 193: 154-163, 2002.
90. Van De Bittner GC, Dubikovskaya EA, Bertozzi CR, and Chang CJ. In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc Natl Acad Sci U S A 107: 21316-21321, 2010.
91. Venè R, Castellani P, Delfino L, Lucibello M, Ciriolo MR, and Rubartelli A. The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets. Antioxid Redox Signal 15: 2439-2453, 2011.
92. Vené R, Delfino L, Castellani P, Balza E, Bertolotti M, Sitia R, and Rubartelli A. Redox remodeling allows and controls B-cell activation and differentiation. Antioxid Redox Signal 13: 1145-1155, 2010.
93. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, Shams SS, Yang H, Varani L, Andersson U, Tracey KJ, Bachi A, Uguccioni M, and Bianchi ME. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209: 1519-1528, 2012.
94. Vezzoli M, Castellani P, Corna G, Castiglioni A, Bosurgi L, Monno A, Brunelli S, Manfredi AA, Rubartelli A, and Rovere-Querini P. High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid Redox Signal 15: 2161-2174, 2011.
95. Wang J and Yi J. Cancer cell killing via ROS: To increase or decrease, that is the question. Cancer Biol Ther 7: 1875-1884, 2008.
96. Wang MT, Honn KV, and Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534, 2007.
97. Wichels A, Biel SS, Gelderblom HR, Brinkhoff T, Muyzer G, and Schutt C. Bacteriophage diversity in the North Sea. Appl Environ Microbiol 64: 4128-4133, 1998.
98. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, and Tracey KJ. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 107: 11942-11947, 2010.
99. Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, and Antoine DJ. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 18: 250-259, 2012.
100. Yang P, Ebbert JO, Sun Z, and Weinshilboum RM. Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review. J Clin Oncol 24: 1761-1769, 2006.
101. Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, and Borst P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-Associated protein. Proc Natl Acad Sci U S A 92: 7690-7694, 1995.
102. Zhang Y, Du Y, Le W, Wang K, Kieffer N, and Zhang J. Redox control of the survival of healthy and diseased cells. Antioxid Redox Signal 15: 2867-2908, 2011.
103. Zhou R, Yazdi AS, Menu P, and Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.